Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.925 USD | +5.98% | -2.66% | -8.72% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.72% | 471M | |
+5.24% | 109B | |
+11.13% | 105B | |
-0.38% | 22.25B | |
-11.94% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.17% | 16.85B | |
+3.38% | 13.76B | |
+36.09% | 12.46B |
- Stock Market
- Equities
- ALLO Stock
- News Allogene Therapeutics, Inc.
- Oppenheimer Adjusts Allogene Therapeutics Price Target to $28 From $32, Maintains Outperform Rating